Patterson D, Jones C
Somatic Cell Genet. 1976 Sep;2(5):429-39. doi: 10.1007/BF01542723.
Mutants of the Chinese hamster ovary cell derived from CHO-K1 have been selected for lack of hypoxanthine-guanine phosphoribosyltransferase (EC 2.4.2.8) (HGPRT) without the use of a drug-resistance protocol. The procedure depends on the use of a parental strain carrying a mutation making it unable to synthetize purines and thus dependent upon exogenously added purines for growth. The standard "BUdR-visible-light" procedure is then used to select those cells which can use adenine but cannot use hypoxanthine as a purine source. These cells are shown to be thioguanine resistant, to be unable to incorporate exogenously added hypoxanthine into purine nucleotides, to complement our other adenine-specific purine auxotrophs, Ade-H and Ade-I but not to complement a cell isolated by virtue of thioguanine resistance, and to lack the activity of HGPRT. The use of such multiply marked mutants and cells related to them for further analysis of purine nucleotide biosynthesis and interconversion is discussed.
已从中国仓鼠卵巢细胞(源自CHO-K1)中筛选出缺乏次黄嘌呤-鸟嘌呤磷酸核糖转移酶(EC 2.4.2.8)(HGPRT)的突变体,且未使用抗药方案。该方法依赖于使用携带突变的亲本菌株,该突变使其无法合成嘌呤,因此生长依赖于外源添加的嘌呤。然后使用标准的“5-溴脱氧尿苷-可见光”方法来筛选那些能够利用腺嘌呤但不能利用次黄嘌呤作为嘌呤来源的细胞。这些细胞表现出对硫鸟嘌呤有抗性,无法将外源添加的次黄嘌呤掺入嘌呤核苷酸中,能与我们其他腺嘌呤特异性嘌呤营养缺陷型Ade-H和Ade-I互补,但不能与因硫鸟嘌呤抗性而分离的细胞互补,并且缺乏HGPRT的活性。讨论了使用此类多重标记的突变体及其相关细胞对嘌呤核苷酸生物合成和相互转化进行进一步分析的情况。